June 20th 2025
The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.
ADC Bio to Develop New Bioconjugation Process
February 13th 2018Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.